Osterweis Capital Management Inc Fate Therapeutics Inc Transaction History

Osterweis Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $192,913 - $459,931	-10,850 Reduced 20.68%	41,605 $1.03 Million
Q1 2022 May 16, 2022	BUY	$29.67 - $60.28 $260,650 - $529,559	8,785 Added 20.12%	52,455 $2.03 Million
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $764,004 - $1.03 Million	-15,970 Reduced 26.78%	43,670 $2.56 Million
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $3.53 Million - $5.71 Million	59,640 New	59,640 $3.54 Million

176

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $123M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.